Morning Call: Tradi...
Health Care: Drugs
Bristol-Myers Squibb Company (BMY: NYSE)
$44.06 0.30 | 0.69%
05/21/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 1.66B | 5.78B | 5.03B | 7.68B |
| Receivables | 3.08B | 3.74B | 3.48B | 3.16B |
| Inventories | 1.66B | 1.38B | 1.20B | 1.41B |
| Other Current Assets | 355.00M | 0.00 | 0.00 | 611.00M |
| Total Current Assets | 9.52B | 15.32B | 13.27B | 13.96B |
| Property, Plant & Equipment, Gross | 9.38B | 8.38B | 8.26B | 8.90B |
| Accumulated Depreciation & Depletion | 4.05B | 3.86B | 3.60B | 3.84B |
| Property, Plant & Equipment, Net | 5.33B | 4.52B | 4.66B | 5.06B |
| Intangibles | 8.78B | 3.12B | 3.37B | 2.86B |
| Other Non-Current Assets | 4.43B | 3.73B | 3.69B | 2.28B |
| Total Non-Current Assets | 26.38B | 17.65B | 17.80B | 17.05B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 35.90B | 32.97B | 31.08B | 31.01B |
| Accounts Payable | 2.20B | 2.60B | 1.98B | 1.71B |
| Short Term Debt | 826.00M | 115.00M | 117.00M | 231.00M |
| Other Current Liabilities | 799.00M | 1.67B | 640.00M | 727.00M |
| Total Current Liabilities | 8.28B | 7.78B | 6.74B | 6.31B |
| Long Term Debt | 6.57B | 5.38B | 5.33B | 6.13B |
| Deferred Income Taxes | 383.00M | 0.00 | 0.00 | 751.00M |
| Other Non-Current Liabilities | 7.03B | 3.95B | 3.37B | 3.03B |
| Minority Interest | 541.00M | 1.55B | 1.41B | 1.25B |
| Total Non-Current Liabilities | 14.00B | 9.23B | 8.62B | 9.85B |
| Total Liabilities | 22.27B | 17.01B | 15.36B | 16.16B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 13.62B | 15.96B | 15.71B | 14.84B |
| Common Par | 221.00M | 220.00M | 220.00M | 220.00M |
| Additional Paid In Capital | 2.69B | 3.11B | 3.68B | 3.77B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 32.73B | 33.07B | 31.64B | 30.76B |
| Treasury Stock | -18.82B | -17.40B | -17.45B | -17.36B |
| Other Equity Adjustments | -3.20B | -3.04B | -2.37B | -2.54B |
| Total Capitalization | 20.19B | 21.33B | 21.04B | 20.97B |
| Total Equity | 13.62B | 15.96B | 15.71B | 14.84B |
| Total Liabilities & Stock Equity | 35.90B | 32.97B | 31.08B | 31.01B |
| Total Common Shares Outstanding | 1.63B | 1.68B | 1.70B | 1.71B |
| Preferred Shares | 5.12K | 5.27K | 5.27K | 5.52K |
| Treasury Shares | 1.14B | 515.00M | 501.00M | 491.00M |
| Basic Weighted Shares Outstanding | 1.67B | 1.70B | 1.71B | 1.97B |
| Diluted Weighted Shares Outstanding | 1.69B | 1.70B | 1.71B | 1.98B |
| Number of Employees | 28000 | 27000 | 27000 | 28000 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with BMY
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- UserThe Best Dividend Stocks
- UserCapt Jer
- Userlennyvb Portfolio 1
- Usersamuel sandler kosher sausage
- ProNavellier & Associates
- ProRenaissance Technologies
- UserHoneypot
- Pondo
- UserJS&JH
Latest BMY Headlines from TheStreet
- Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLA 05.21.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons 05.20.13 | 08:05 pm
- 5 Drugs Stocks On The Rise 05.20.13 | 01:05 pm
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner 05.17.13 | 05:05 pm
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Analysts' Actions: AMAT ARUN BMY DE WSM 05.17.13 | 08:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - 5 Stock Trades for S&P 1,700 05.16.13 | 07:05 am
- ASCO '13 Preview: New 'Anti-PD-1' Therapies Shrink Tumors 05.15.13 | 06:05 pm
- 5 Stocks Boosting The Drugs Industry Higher 05.15.13 | 01:05 pm
Press Releases for BMY
- Santaris Pharma Announces A Worldwide Discovery Alliance With Bristol-Myers Squibb For RNA-targeted Medicines - PR Newswire 04.16.13 | 02:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Bristol-Myers Squibb Awards Two Grants To Support Comprehensive Cancer Community Collaboration At Several Hospitals In New Jersey - Business Wire 03.13.13 | 09:03 am
- Bristol-Myers Squibb Announces Dividend - Business Wire 03.07.13 | 05:03 pm
- Bristol-Myers Squibb To Present At Barclays Global Health Care Conference - Business Wire 03.05.13 | 04:03 pm
- Bristol-Myers Squibb To Present At Cowen And Company Health Care Conference - Business Wire 02.27.13 | 04:02 pm
- Bristol-Myers Squibb To Take Part In Citi 2013 Global Health Care Conference - Business Wire 02.19.13 | 04:02 pm
- Bristol-Myers Squibb Appoints Ann Powell Judge Senior Vice President, Human Resources - Business Wire 02.14.13 | 08:02 am
- Bristol-Myers Squibb Enters A Collaboration Agreement For Several Over-the-Counter Medicines With Reckitt Benckiser Group Plc - Business Wire 02.12.13 | 07:02 am
- Bristol-Myers Squibb To Take Part In Leerink Swann Global Health Care Conference - Business Wire 02.06.13 | 02:02 pm
Partner Headlines for BMY
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- A Flight To Safety Or Crash And Burn? - Seeking Alpha 04.13.13 | 09:04 am
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 03, 2013 - NASDAQ 04.02.13 | 01:04 pm
- Analysts: United Continental is Looking Good and 3 New Opinions Investors Must Read Now - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- Team Alpha And The Foundations For Financial Freedom - Seeking Alpha 03.23.13 | 08:03 am
- AstraZeneca puts its faith in science - Financial Times 03.21.13 | 06:03 pm
